Publications

Phase contrast measured head to head against cone-beam CT on real dental questions — the comparison a radiologist needs before taking the method seriously.

Which mask pattern actually maximises the signal — a question everyone building these setups asks, answered with numbers instead of folklore.

Orientation and anisotropy from one image pair, without assuming what the scattering profile looks like. This is the method behind SerPy.

code

The bridge paper: what a dark-field pixel measures, expressed in the units a SAXS beamline already uses.

A like-for-like comparison of every speckle-tracking algorithm in circulation, so the choice stops being a matter of which lab you trained in.

Cement setting watched in three dimensions as it happens, at the nanoscale — the same wave-optical toolbox, pointed at a material rather than a tissue.

Validated against SAXS anisotropy on a laboratory source — the result that made the lab-based programme credible.

Myelin mapped across a whole brain with no sectioning and no stain, in models of white-matter injury.

The Fokker–Planck route to directional dark-field — the model-based approach our own statistical method is measured against.

The founding MoBI paper: a random mask and an ordinary laboratory source are enough to retrieve the wavefront. This is what made everything since possible away from a synchrotron.

Attenuation, phase and dark-field pulled from the same speckle images at once: the multi-channel picture the viewer on our home page illustrates.

The first clinical case imaged by synchrotron CT at a substantially reduced dose — evidence that the physics survives contact with a patient.

Lead found in the ink of the Herculaneum scrolls, overturning the assumption that ancient ink was carbon only — and explaining why the letters can be read at all.

Text read inside a carbonised scroll that cannot be unrolled. Still the clearest demonstration of why phase, not absorption, is the useful contrast.

Whole human breast tumours diagnosed in three dimensions at a dose compatible with screening — the result that put phase contrast on the clinical map.